2017-2022 Global and Japan Osteoarthritis Pain Drugs Market Analysis Report

Published: Aug, 2017 | Pages: 119 | Publisher: JP Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Osteoarthritis Pain Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Osteoarthritis Pain Drugs market's development status and future trend in the global and Japan. It splits Osteoarthritis Pain Drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
    Johnson & Johnson (US)
    Pfizer (US)
    GlaxoSmithKline (UK)
    Mylan (US)
    Lilly (US)
    Sanofi (France)
    Abbott Laboratories (US)
    Bayer (Germany)
    Almatica Pharma (US)
    Teva Pharmaceutical Industries (Israel)
    Iroko Pharmaceuticals (US)

Geographically, this report splits the Global market into the following regions:
    Asia Pacific
        Japan
            Tokyo
            Yokohama
            Osaka
            Nagoya
            Others
        China
        Korea
        India
        Others
    Europe
        France
        Germany
        United Kingdom
        Italy
        Russia
        Others
    North America
        United States
        Canada
    Latin America
        Brazil
        Mexico
        Others
    Southeast Asia
        Singapore
        Malaysia
        Vietnam
        Myanmar
        Thailand
        Indonesia
        Philippines
        Others
    Middle East & Africa
        Saudi Arabia
        Iran
        UAE
        Turkey
        Israel
        Egypt
        South Africa
        Others

On the basis of product, the Osteoarthritis Pain Drugs market is primarily split into
By Usage Mode
    Oral
    Injection
    External
By Form
    Tablets
    Ointment
    Spray

Key Applications
    Medical Care
    Personal Care
    Other

 Table of Contents

2017-2022 Global and Japan Osteoarthritis Pain Drugs Market Analysis Report
1 Osteoarthritis Pain Drugs Overview
    1.1 Product Overview and Scope of Osteoarthritis Pain Drugs
    1.2 Global and Japan Osteoarthritis Pain Drugs Market by Applications/End Users
        1.2.1 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share Comparison by Applications (2012-2017)
            1.2.1.1 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share by Applications (2012-2017)
            1.2.1.2 Japan Osteoarthritis Pain Drugs Sales Growth Rate (%) by Applications (2012-2017)
            1.2.1.3 Market Drivers and Opportunities
        1.2.2 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share Comparison by Applications (2012-2017)
        1.2.3 Global Osteoarthritis Pain Drugs Sales by Application (2012-2017)
            1.2.3.1 Global Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share by Applications (2012-2017)
            1.2.3.2 Global Osteoarthritis Pain Drugs Sales Growth Rate (%) by Applications (2012-2017)
            1.2.3.3 Market Drivers and Opportunities
        1.2.4 Global Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share Comparison by Applications (2012-2017)
        1.2.5 Medical Care
        1.2.6 Personal Care
        1.2.7 Other
    1.3 Global and Japan Market Size (Sales and Revenue) of Osteoarthritis Pain Drugs (2012-2017)
        1.3.1 Japan Market Size (Sales and Revenue) of Osteoarthritis Pain Drugs (2012-2017)
            1.3.1.1 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) (2012-2017)
            1.3.1.2 Japan Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
        1.3.2 Global Market Size (Sales and Revenue) of Osteoarthritis Pain Drugs (2012-2017)
            1.3.2.1 Global Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) (2012-2017)
            1.3.2.2 Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    1.4 Global and Japan Classification of Osteoarthritis Pain Drugs by Usage Mode
        1.4.1 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share by Usage Mode (2012-2017)
        1.4.2 Global Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share by Usage Mode (2012-2017)
        1.4.3 Japan Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share by Usage Mode (2012-2017)
        1.4.4 Global Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share by Usage Mode (2012-2017)
        1.4.5 Japan Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
        1.4.6 Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
        1.4.7 Japan Osteoarthritis Pain Drugs Sales Growth Rate (%) by Usage Mode (2012-2017)
        1.4.8 Global Osteoarthritis Pain Drugs Sales Growth Rate (%) by Usage Mode (2012-2017)
        1.4.9 Oral
        1.4.10 Injection
        1.4.11 External
    1.5 Global and Japan Classification of Osteoarthritis Pain Drugs by Form
        1.5.1 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share by Form (2012-2017)
        1.5.2 Global Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share by Form (2012-2017)
        1.5.3 Japan Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share by Form (2012-2017)
        1.5.4 Global Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share by Form (2012-2017)
        1.5.5 Japan Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
        1.5.6 Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
        1.5.7 Japan Osteoarthritis Pain Drugs Sales Growth Rate (%) by Form (2012-2017)
        1.5.8 Global Osteoarthritis Pain Drugs Sales Growth Rate (%) by Form (2012-2017)
        1.5.9 Tablets
        1.5.10 Ointment
        1.5.11 Spray

2 Global and Japan Osteoarthritis Pain Drugs Market Competition by Players/Manufacturers
    2.1 Japan Osteoarthritis Pain Drugs Market Competition by Players/Manufacturers
    2.1.1 Japan Osteoarthritis Pain Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.1.2 Japan Osteoarthritis Pain Drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.1.3 Japan Osteoarthritis Pain Drugs Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
    2.1.4 Japan Osteoarthritis Pain Drugs Market Competitive Situation and Trends
        2.1.4.1 Japan Osteoarthritis Pain Drugs Market Concentration Rate
        2.1.4.2 Japan Osteoarthritis Pain Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
    2.1.5 Japan Players/Manufacturers Osteoarthritis Pain Drugs Manufacturing Base Distribution, Sales Area, Product Types
    2.2 Global Osteoarthritis Pain Drugs Market Competition by Players/Manufacturers
    2.2.1 Global Osteoarthritis Pain Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2.2 Global Osteoarthritis Pain Drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.2.3 Global Osteoarthritis Pain Drugs Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
    2.2.4 Global Osteoarthritis Pain Drugs Market Competitive Situation and Trends
        2.2.4.1 Global Osteoarthritis Pain Drugs Market Concentration Rate
        2.2.4.2 Global Osteoarthritis Pain Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
    2.2.5 Global Players/Manufacturers Osteoarthritis Pain Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 Global and Japan Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
    3.1 Asia Pacific Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
        3.1.1 Japan Osteoarthritis Pain Drugs Sales and Revenue  (2012-2017)
            3.1.1.1 Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share  (2012-2017)
            3.1.1.2 Japan Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.1.3 Japan Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.1.2 China Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.1.2.1 China Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.1.2.2 China Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.2.3 China Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.1.3 Korea Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.1.3.1 Korea Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.1.3.2 Korea Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.3.3 Korea Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.1.4 India Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.1.4.1 India Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.1.4.2 India Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.4.3 India Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.1.5 Others Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.1.5.1 Others Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.1.5.2 Others Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.1.5.3 Others Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
    3.2 Europe Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
        3.2.1 France Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.2.1.1 France Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.2.1.2 France Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.1.3 France Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.2.2 Germany Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.2.2.1 Germany Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.2.2.2 Germany Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.2.3 Germany Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.2.3 United Kingdom Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.2.3.1 United Kingdom Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.2.3.2 United Kingdom Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.3.3 United Kingdom Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.2.4 Italy Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.2.4.1 Italy Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.2.4.2 Italy Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.4.3 Italy Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.2.5 Russia Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.2.5.1 Russia Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.2.5.2 Russia Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.5.3 Russia Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.2.6 Others Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.2.6.1 Others Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.2.6.2 Others Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.2.6.3 Others Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
    3.3 North America Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
        3.3.1 United States Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.3.1.1 United States Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.3.1.2 United States Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.3.1.3 United States Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.3.2 Canada Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.3.2.1 Canada Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.3.2.2 Canada Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.3.2.3 Canada Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
    3.4 Latin America Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
        3.4.1 Brazil Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.4.1.1 Brazil Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.4.1.2 Brazil Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.1.3 Brazil Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.4.2 Mexico Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.4.2.1 Mexico Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.4.2.2 Mexico Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.2.3 Mexico Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.4.3 Others Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.4.3.1 Others Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.4.3.2 Others Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.4.3.3 Others Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
    3.5 Southeast Asia Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
        3.5.1 Singapore Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.1.1 Singapore Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.1.2 Singapore Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.1.3 Singapore Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.2 Malaysia Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.2.1 Malaysia Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.2.2 Malaysia Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.2.3 Malaysia Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.3 Vietnam Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.3.1 Vietnam Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.3.2 Vietnam Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.3.3 Vietnam Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.4 Myanmar Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.4.1 Myanmar Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.4.2 Myanmar Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.4.3 Myanmar Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.5 Thailand Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.5.1 Thailand Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.5.2 Thailand Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.5.3 Thailand Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.6 Indonesia Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.6.1 Indonesia Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.6.2 Indonesia Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.6.3 Indonesia Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.7 Philippines Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.7.1 Philippines Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.7.2 Philippines Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.7.3 Philippines Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.5.8 Others Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.5.8.1 Others Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.5.8.2 Others Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.5.8.3 Others Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
    3.6 Middle East & Africa Osteoarthritis Pain Drugs Sales and Revenue by Regions (2012-2017)
        3.6.1 Saudi Arabia Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.1.1 Saudi Arabia Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.1.2 Saudi Arabia Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.1.3 Saudi Arabia Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.2 Iran Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.2.1 Iran Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.2.2 Iran Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.2.3 Iran Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.3 UAE Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.3.1 UAE Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.3.2 UAE Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.3.3 UAE Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.4 Turkey Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.4.1 Turkey Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.4.2 Turkey Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.4.3 Turkey Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.5 Israel Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.5.1 Israel Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.5.2 Israel Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.5.3 Israel Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.6 Egypt Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.6.1 Egypt Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.6.2 Egypt Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.6.3 Egypt Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.7 South Africa Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.7.1 South Africa Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.7.2 South Africa Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.7.3 South Africa Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)
        3.6.8 Others Osteoarthritis Pain Drugs Sales and Revenue (2012-2017)
            3.6.8.1 Others Osteoarthritis Pain Drugs Sales (K Pcs) and Market Share (2012-2017)
            3.6.8.2 Others Osteoarthritis Pain Drugs Revenue (Million USD) and Market Share (2012-2017)
            3.6.8.3 Others Osteoarthritis Pain Drugs Price (USD/Pcs)(2012-2017)

4 Global and Japan Osteoarthritis Pain Drugs Players/Manufacturers Profiles and Sales Data
    4.1 Johnson & Johnson (US)
        4.1.1 Company Basic Information, Manufacturing Base and Competitors
        4.1.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.1.2.1 Product A
            4.1.2.2 Product B
        4.1.3 Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.1.4 Main Business/Business Overview
    4.2 Pfizer (US)
        4.2.1 Company Basic Information, Manufacturing Base and Competitors
        4.2.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.2.2.1 Product A
            4.2.2.2 Product B
        4.2.3 Pfizer (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.2.4 Main Business/Business Overview
    4.3 GlaxoSmithKline (UK)
        4.3.1 Company Basic Information, Manufacturing Base and Competitors
        4.3.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.3.2.1 Product A
            4.3.2.2 Product B
        4.3.3 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.3.4 Main Business/Business Overview
    4.4 Mylan (US)
        4.4.1 Company Basic Information, Manufacturing Base and Competitors
        4.4.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.4.2.1 Product A
            4.4.2.2 Product B
        4.4.3 Mylan (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.4.4 Main Business/Business Overview
    4.5 Lilly (US)
        4.5.1 Company Basic Information, Manufacturing Base and Competitors
        4.5.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.5.2.1 Product A
            4.5.2.2 Product B
        4.5.3 Lilly (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.5.4 Main Business/Business Overview
    4.6 Sanofi (France)
        4.6.1 Company Basic Information, Manufacturing Base and Competitors
        4.6.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.6.2.1 Product A
            4.6.2.2 Product B
        4.6.3 Sanofi (France) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.6.4 Main Business/Business Overview
    4.7 Abbott Laboratories (US)
        4.7.1 Company Basic Information, Manufacturing Base and Competitors
        4.7.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.7.2.1 Product A
            4.7.2.2 Product B
        4.7.3 Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.7.4 Main Business/Business Overview
    4.8 Bayer (Germany)
        4.8.1 Company Basic Information, Manufacturing Base and Competitors
        4.8.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.8.2.1 Product A
            4.8.2.2 Product B
        4.8.3 Bayer (Germany) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.8.4 Main Business/Business Overview
    4.9 Almatica Pharma (US)
        4.9.1 Company Basic Information, Manufacturing Base and Competitors
        4.9.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.9.2.1 Product A
            4.9.2.2 Product B
        4.9.3 Almatica Pharma (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.9.4 Main Business/Business Overview
    4.10 Teva Pharmaceutical Industries (Israel)
        4.10.1 Company Basic Information, Manufacturing Base and Competitors
        4.10.2 Osteoarthritis Pain Drugs Product Category, Application and Specification
            4.10.2.1 Product A
            4.10.2.2 Product B
        4.10.3 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        4.10.4 Main Business/Business Overview
    4.11 Iroko Pharmaceuticals (US)

5 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
    5.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
        5.1.1 Key Raw Materials
        5.1.2 Price Trend of Key Raw Materials
        5.1.3 Key Suppliers of Raw Materials
        5.1.4 Market Concentration Rate of Raw Materials
    5.2 Proportion of Manufacturing Cost Structure
        5.2.1 Raw Materials
        5.2.2 Labor Cost
        5.2.3 Manufacturing Expenses
    5.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs

6 Industrial Chain, Sourcing Strategy and Downstream Buyers
    6.1 Osteoarthritis Pain Drugs Industrial Chain Analysis
    6.2 Upstream Raw Materials Sourcing
    6.3 Raw Materials Sources of Osteoarthritis Pain Drugs Major Players/Manufacturers in 2016
    6.4 Downstream Buyers

7 Marketing Strategy Analysis, Distributors/Traders
    7.1 Marketing Channel
        7.1.1 Direct Marketing
        7.1.2 Indirect Marketing
        7.1.3 Marketing Channel Development Trend
    7.2 Market Positioning
        7.2.1 Pricing Strategy
        7.2.2 Brand Strategy
        7.2.3 Target Client
    7.3 Distributors/Traders List

8 Market Effect Factors Analysis
    8.1 Technology Progress/Risk
        8.1.1 Substitutes Threat
        8.1.2 Technology Progress in Related Industry
    8.2 Consumer Needs/Customer Preference Change
    8.3 Economic/Political Environmental Change

9 Global and Japan Osteoarthritis Pain Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global and Japan Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global and Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Type (2017-2022)
        9.2.1 by Usage Mode
        9.2.2 by Form
    9.3 Global and Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    9.4 Global and Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)

10 Research Findings and Conclusion

11 Methodology and Data Source
    11.1 Methodology/Research Approach
        11.1.1 Research Programs/Design
        11.1.2 Market Size Estimation
        11.1.3 Market Breakdown and Data Triangulation
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Disclaimer
    11.4 Author List

List of Tables and Figures

    Figure Product Picture of Osteoarthritis Pain Drugs
    Table Japan Osteoarthritis Pain Drugs Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Japan Sales Market Share (%) of Osteoarthritis Pain Drugs by Applications in 2016
    Table Global Osteoarthritis Pain Drugs Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Global Sales Market Share (%) of Osteoarthritis Pain Drugs by Applications in 2016
    Figure Medical Care Examples
    Table Key Downstream Customer in Medical Care
    Figure Personal Care Examples
    Table Key Downstream Customer in Personal Care
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure Oral Product Picture
    Figure Injection Product Picture
    Figure External Product Picture
    Figure Tablets Product Picture
    Figure Ointment Product Picture
    Figure Spray Product Picture
    Table Johnson & Johnson (US) Basic Information List
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Pfizer (US) Basic Information List
    Table Pfizer (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Pfizer (US) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Pfizer (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table GlaxoSmithKline (UK) Basic Information List
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Mylan (US) Basic Information List
    Table Mylan (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Mylan (US) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Mylan (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Lilly (US) Basic Information List
    Table Lilly (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Lilly (US) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Lilly (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Sanofi (France) Basic Information List
    Table Sanofi (France) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Sanofi (France) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Sanofi (France) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Abbott Laboratories (US) Basic Information List
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Bayer (Germany) Basic Information List
    Table Bayer (Germany) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Bayer (Germany) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Bayer (Germany) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Almatica Pharma (US) Basic Information List
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Teva Pharmaceutical Industries (Israel) Basic Information List
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Growth Rate (%)(2012-2017)
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Market Share (%) in Japan (2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Revenue Market Share (%) in Japan (2012-2017)
    Table Iroko Pharmaceuticals (US) Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Osteoarthritis Pain Drugs
    Figure Manufacturing Process Analysis of Osteoarthritis Pain Drugs
    Figure Osteoarthritis Pain Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Osteoarthritis Pain Drugs Major Players/Manufacturers in 2016
    Table Major Buyers of Osteoarthritis Pain Drugs
    Table Distributors/Traders List
    Figure Japan Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Type in 2017
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Type in 2017
    Table Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2017
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2017
    Table Japan Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Japan Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Japan Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources